Source link.
If the Food and Drug Administration (FDA) authorizes the two-shot program, it will become the first Covid vaccine readily available to this age group in the United States.The companies said Tuesday that they began submitting their formal application “following a demand” from the FDA, which apparently wants to get the process moving quickly.In a tweet quickly after the announcement, the FDA stated it will hold a meeting in two weeks, on February 15, to think about the demand.” Having a safe and reliable vaccine available for kids in this age group is a top priority for the agency,” said interim FDA head Janet Woodcock, who added that the FDA asked for the application “in light of the recent Omicron surge.” If 2 doses are licensed, parents will have the chance to start a Covid-19 vaccination series for their kids while waiting for potential permission of a third dosage,” he added.To limit side results for this young age group, Pfizer chose to significantly reduce the dosage of its vaccine, opting for only 3 micrograms per jab versus 30 for those over 12 years old, and 10 for ages 5 to 11.
Provided on: 02/02/2022 – 03:15
Pfizer and BioNTech said Tuesday they are looking for emergency permission from United States health regulators for use of their Covid vaccine for children aged over 6 months and under 5 years.
